Display Settings:

Format

Send to:

Choose Destination
    Mol Aspects Med. 1997;18 Suppl:S237-40.

    Q10 therapy in patients with idiopathic Parkinson's disease.

    Source

    Department of Neurology, University Hospital Nijmegen, The Netherlands.

    Abstract

    A 3-month open-label trial was performed to evaluate the efficacy of 200 mg Q10 daily in 10 patients with Parkinson's disease. Motor performance was assessed with UPDRS and motor tests. There was no significant effect on the clinical ratings.

    PMID:
    9266528
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk